Mouse models for studying HCV vaccines and therapeutic antibodies

Jenna M. Gaska, Qiang Ding, Alexander Ploss

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

In spite of the immense progress in hepatitis C virus (HCV) research, efforts to prevent infection, such as generating a vaccine, have not yet been successful. The high price tag associated with current treatment options for chronic infection and the spike in new infections concurrent with growing opioid abuse are strong motivators for developing effective immunization and understanding neutralizing antibodies’ role in preventing infection. Humanized mice—both human liver chimeras as well as genetically humanized models—are important platforms for testing both possible vaccine candidates as well as antibody-based therapies. This chapter details the variety of ways humanized mouse technology can be employed in pursuit of learning how HCV infection can be prevented.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages481-503
Number of pages23
DOIs
StatePublished - 2019

Publication series

NameMethods in Molecular Biology
Volume1911
ISSN (Print)1064-3745

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics

Keywords

  • Hepatitis C virus
  • Humanized mice
  • Immunization
  • Neutralizing antibodies

Fingerprint Dive into the research topics of 'Mouse models for studying HCV vaccines and therapeutic antibodies'. Together they form a unique fingerprint.

  • Cite this

    Gaska, J. M., Ding, Q., & Ploss, A. (2019). Mouse models for studying HCV vaccines and therapeutic antibodies. In Methods in Molecular Biology (pp. 481-503). (Methods in Molecular Biology; Vol. 1911). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-8976-8_33